What is Alström syndrome

Alström syndrome is a rare, multisystem genetic disorder characterized primarily by progressive vision loss, hearing impairment, and metabolic disturbances such as childhood obesity and type 2 diabetes. It is caused by mutations in the ALMS1 gene, which affects the function of cilia, the tiny, hair-like structures found on cells throughout the body.

What are the primary symptoms of Alström syndrome?

Because the ALMS1 gene is expressed in nearly every tissue in the human body, Alström syndrome impacts multiple organ systems. The clinical presentation is progressive, meaning symptoms often evolve over time. Common manifestations include:

• Vision: Nearly all individuals experience cone-rod dystrophy, which typically begins in infancy with sensitivity to light (photophobia) and leads to nystagmus (involuntary eye movement) and progressive vision loss, often resulting in legal blindness by the second decade of life.


• Hearing: Progressive sensorineural hearing loss usually begins in childhood and affects the majority of patients.


• Metabolic Health: Infants and children often develop severe obesity. This is frequently accompanied by insulin resistance, hyperinsulinemia, and early-onset type 2 diabetes.


• Cardiac and Organ Function: Dilated cardiomyopathy is a significant concern, particularly in infancy or adolescence. Additionally, many patients experience hepatic (liver) dysfunction, renal (kidney) impairment, and endocrine issues like hypothyroidism.

How common is Alström syndrome and who does it affect?

Alström syndrome is an exceptionally rare condition. While precise global prevalence is difficult to determine due to underdiagnosis, it is estimated to affect fewer than 1 in 100,000 to 1,000,000 individuals worldwide. The condition affects both males and females equally and has been reported in diverse ethnic populations globally. Symptoms typically appear in the first few months of life, with vision and hearing issues often serving as the initial clinical markers for parents and pediatricians.

What is the underlying cause of Alström syndrome?

Alström syndrome is an autosomal recessive disorder, meaning an individual must inherit two copies of a mutated ALMS1 gene—one from each parent—to manifest the disease. The ALMS1 gene provides instructions for creating a protein localized to the centrosome and the base of cilia. Cilia are essential for sensory perception and cell signaling; when they fail to function correctly, it leads to the multisystem dysfunction characteristic of Alström syndrome.

How does Alström syndrome differ from similar conditions?

It is common to confuse Alström syndrome with other ciliopathies, such as Bardet-Biedl syndrome. While both involve obesity and vision loss, Alström syndrome is distinct because it does not typically involve the polydactyly (extra fingers or toes) or the cognitive impairment often associated with other similar genetic syndromes. Furthermore, the specific pattern of early-onset heart disease and the rapid progression of insulin resistance are hallmark features that help clinicians differentiate this condition from other metabolic and vision-related disorders.

Next steps

• Consult with a clinical geneticist to confirm a diagnosis through ALMS1 molecular genetic testing.


• Schedule multidisciplinary evaluations, including cardiology, endocrinology, ophthalmology, and audiology, to manage the multisystem nature of Alström syndrome.


• Connect with the 45 members of the DiseaseMaps.org community who are living with or caring for someone with this condition to share experiences and coping strategies.


• Reach out to specialized patient organizations, such as Alström Syndrome International, for the latest information on clinical trials and support resources.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Alström syndrome overview.


• Orphanet: Rare disease database entry for Alström syndrome (ORPHA76).


• OMIM (Online Mendelian Inheritance in Man): Entry #203800 for ALMS1 gene mutations.


• Alström Syndrome International: Patient-centered resources and research updates.